UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype

Neurobiology of aging, 2015-10, Vol.36 (10), p.2687-2701

2015

Volltextzugriff (PDF)

Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele

Brain research, 2016-11, Vol.1651, p.11-16

2016

Volltextzugriff (PDF)

Neuroimaging and biochemical markers in the three variants of primary progressive aphasia

Dementia and geriatric cognitive disorders, 2013-01, Vol.35 (1-2), p.106-117

2013

Volltextzugriff (PDF)

The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer's disease

Archives of gerontology and geriatrics, 2010-03, Vol.50 (2), p.171-174

2010

Volltextzugriff (PDF)

Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: Implications for early diagnosis and treatment

Archives of gerontology and geriatrics, 2011-01, Vol.52 (1), p.18-22

2011

Volltextzugriff (PDF)

Evaluación de la información suministrada por el médico especialista sobre la enfermedad de Alzheimer y de la retención lograda por los cuidadores del enfermo

Neurología (Barcelona, Spain), 2012-10, Vol.27 (8), p.453-471

2012

Volltextzugriff (PDF)

Predictors of response to the 13.3 and 9.5 mg/24 h rivastigmine patch: The optimizing /INS;transdermal exelon in mild-to-moderate Alzheimer's disease (optima) study

Journal of the neurological sciences, 2013-10, Vol.333, p.e336-e336

2013

Volltextzugriff (PDF)

High-dose 13.3 mg/24 h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use

Journal of the neurological sciences, 2013-10, Vol.333, p.e348-e348

2013

Volltextzugriff (PDF)

Whole genome analysis in a consanguineous family with early onset Alzheimer's disease

Neurobiology of aging, 2009-12, Vol.30 (12), p.1986-1991

2009

Volltextzugriff (PDF)

Perfil del cuidador informal asociado al manejo clínico del paciente con enfermedad de Alzheimer no respondedor al tratamiento sintomático de la enfermedad

Neurología (Barcelona, Spain), 2011-11, Vol.26 (9), p.518-527

2011

Volltextzugriff (PDF)

Assessment of the information provided by the medical specialist on Alzheimer's disease and that retained by the patient caregivers

Neurología (Barcelona, English ed. ), 2012-10, Vol.27 (8), p.453-471

2012

Volltextzugriff (PDF)

Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease

Neurology, 2011-05, Vol.76 (20), p.1720-1725

2011

Volltextzugriff (PDF)

Profile of the informal carer associated with the clinical management of the Alzheimer's disease patient refractory to symptomatic treatment of the disease

Neurología (Barcelona, English ed. ), 2011-11, Vol.26 (9), p.518-527

2011

Volltextzugriff (PDF)

The European Prevention of Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0

The Journal of Prevention of Alzheimer's Disease, 2020-01, Vol.7 (1), p.8-13

2020

Volltextzugriff (PDF)

From mild cognitive impairment to prodromal Alzheimer disease: A nosological evolution

European geriatric medicine, 2010, Vol.1 (3), p.146-154

2010

Volltextzugriff (PDF)

PICOGEN: experiencia de 5 años de un programa de asesoramiento genético en demencia

Neurología (Barcelona, Spain), 2011-04, Vol.26 (3), p.143-149

2011

Volltextzugriff (PDF)

Nueva mutación en el gen PSEN1 (E120G) asociada a enfermedad de Alzheimer de inicio precoz

Neurología (Barcelona, Spain), 2010, Vol.25 (1), p.13-16

2010

Volltextzugriff (PDF)

Anti-Tau Trials for Alzheimer’s Disease: A Report from the EU/US/CTAD Task Force

The Journal Of Prevention of Alzheimer's Disease, 2019, Vol.6 (3), p.157-163

2019

Volltextzugriff (PDF)

PICOGEN: Five years experience with a genetic counselling program for dementia

Neurología (Barcelona, English ed. ), 2011, Vol.26 (3), p.143-149

2011

Volltextzugriff (PDF)

New mutation in the PSEN1 (E120G) gene associated with early onset Alzheimer's disease

Neurología (Barcelona, English ed. ), 2010, Vol.25 (1), p.13-16

2010

Volltextzugriff (PDF)

Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor

Neurology, 1999-11, Vol.53 (8), p.1719-1719

1999

Volltextzugriff (PDF)

Predictors of response to the 13.3 and 9.5mg/24h rivastigmine patch: The optimizing /INS;transdermal exelon in mild-to-moderate Alzheimer's disease (optima) study

Journal of the neurological sciences, 2013-10, Vol.333, p.e336

2013

Volltextzugriff (PDF)

High-dose 13.3mg/24h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use

Journal of the neurological sciences, 2013-10, Vol.333, p.e348

2013

Volltextzugriff (PDF)

Problem-solving abilities and frontal lobe cortical thickness in healthy aging and mild cognitive impairment

Journal of the International Neuropsychological Society, 2010-09, Vol.16 (5), p.836-845

2010

Volltextzugriff (PDF)

Diagnostic validity of the Alzheimer's disease functional assessment and change scale in mild cognitive impairment and mild to moderate Alzheimer's disease

Dementia and geriatric cognitive disorders, 2014-01, Vol.37 (5-6), p.366-375

2014

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(33)
Buchkapitel
(2)

Sprache

Englisch
(28)
Spanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype

Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele

Neuroimaging and biochemical markers in the three variants of primary progressive aphasia

The memory alteration test (M@T) discriminates between subjective memory complaints, mild cognitive impairment and Alzheimer's disease

Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: Implications for early diagnosis and treatment

Evaluación de la información suministrada por el médico especialista sobre la enfermedad de Alzheimer y de la retención lograda por los cuidadores del enfermo

Predictors of response to the 13.3 and 9.5 mg/24 h rivastigmine patch: The optimizing /INS;transdermal exelon in mild-to-moderate Alzheimer's disease (optima) study

High-dose 13.3 mg/24 h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use

Whole genome analysis in a consanguineous family with early onset Alzheimer's disease

Perfil del cuidador informal asociado al manejo clínico del paciente con enfermedad de Alzheimer no respondedor al tratamiento sintomático de la enfermedad

Assessment of the information provided by the medical specialist on Alzheimer's disease and that retained by the patient caregivers

Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease

Profile of the informal carer associated with the clinical management of the Alzheimer's disease patient refractory to symptomatic treatment of the disease

The European Prevention of Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0

From mild cognitive impairment to prodromal Alzheimer disease: A nosological evolution

PICOGEN: experiencia de 5 años de un programa de asesoramiento genético en demencia

Nueva mutación en el gen PSEN1 (E120G) asociada a enfermedad de Alzheimer de inicio precoz

Anti-Tau Trials for Alzheimer’s Disease: A Report from the EU/US/CTAD Task Force

PICOGEN: Five years experience with a genetic counselling program for dementia

New mutation in the PSEN1 (E120G) gene associated with early onset Alzheimer's disease

Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor

Predictors of response to the 13.3 and 9.5mg/24h rivastigmine patch: The optimizing /INS;transdermal exelon in mild-to-moderate Alzheimer's disease (optima) study

High-dose 13.3mg/24h rivastigmine patch efficacy and safety in mild-to-moderate Alzheimer's disease with and without concomitant memantine use

Problem-solving abilities and frontal lobe cortical thickness in healthy aging and mild cognitive impairment

Diagnostic validity of the Alzheimer's disease functional assessment and change scale in mild cognitive impairment and mild to moderate Alzheimer's disease

Suchergebnisse filtern